會員登入
註冊
Sunny Pharmtech hits another FDA milestone! AMA-S has received FDA approval.
2023-12-31 / GlobalBio & Investment
SunnyPharmtechhitsanotherFDAmilestone! CongratulationstoSunnyPharmtechInc(6676.TWO)ontheirnewsuccess!TheirCPA-IsmoothlyshippedtotheU.S.earlierthismonth,andnowtheAMA-S(AminocaproicAcidSolution)hasrecei...
Hualien Tzu Chi Hospital administers Taiwan's first CAR-T cell therapy
2023-12-31 / GlobalBio & Investment
HualienTzuChiHospitalmarksamilestoneonJan2ndbyadministeringTaiwan'sfirstCAR-TcelltherapyunderNationalHealthInsurance.Thisinnovativetreatment,conditionallyincludedinthetemporarypaymentlistsinceNove...
Reflecting on 2023: a year filled with hope, challenges, and resilience in biomedicine
2023-12-31 / GlobalBio & Investment
Reflectingon2023:ayearfilledwithhope,challenges,andresiliencein #biomedicine.Let’srevisitthehighlightsandembrace2024withenthusiasm! Wewanttothankyouforyourunwaveringsupportinexploringthewonderso...
Join BE Health's Proof of Clinical Evidence Acceleration Program before the deadline!
2023-12-31 / GlobalBio & Investment
Callallinnovators!JoinBEHealth's #PoC (ProofofClinicalEvidence)AccelerationProgrambeforethedeadline!Tailoredforprecisionmedicine,medicaldevices,anddigitalhealth,itoffers5-6monthsofsupport,a$500,00...
Prof. Cheng-Hsun Chiu emphasizes the critical need for a "Virology to Clinical Blueprint"
2023-12-31 / GlobalBio & Investment
Preparetoprevent#2:WeareexcitedtoshareinsightsfromProf.Cheng-HsunChiu,DeputySuperintendentat 長庚醫院.HeisalsotheleaderofAdvageneBiopharma'sCOVID-19drugAD17002-SC'sphase2atrial.Prof.Chiuemphasizes...
Dr. Tse Wen Chang, Taiwan's antibody pioneer, invented Xolair which was the first anti-IgE antibody
2023-12-31 / GlobalBio & Investment
Excitingnewsintheantibodyworld!Dr.TseWenChang,Taiwan'santibodypioneer,inventedXolair(#omalizumab)whichwasthefirstanti-IgEantibody.FDAisexpectedtoreviewitssBLAsubmittedbyRocheforfoodallergybyQ12024...
Learn from Dr. Andrea Carfi, Moderna’s Chief Scientific Officer, about their mRNA library...
2023-12-31 / GlobalBio & Investment
Preparetoprevent#1Prepareforthenextpandemic?Moderna’svaccinestrategyisunderway!Howdotheyusepastexperiencestoswiftlydevelopvaccinesagainstunknownthreats?LearnfromDr. AndreaCarfi, Moderna’sC...
Jellox partnered with China Medical University Hospital to bring digital pathology tech to Malaysia
2023-12-31 / GlobalBio & Investment
Kudosto JelloXBiotechInc. foradvancinghealthcaredigitizationinMalaysia!!JelloxpartneredwithChinaMedicalUniversityHospital(#CMUH)tobringdigitalpathologytechtoMalaysiaunderTaiwan's"OneCountry,O...
BRIM Biotechnology, Inc. ’s dry eye drug missed the primary goal in its late-stage trial
2023-12-31 / GlobalBio & Investment
Everysetbackisasteppingstone!Thejourneyofdrugdevelopmentisascientificexploration.Eachhurdleisn’ttheendgame. BRIMBiotechnology,Inc. ’sdryeyedrugmissedtheprimarygoalinitslate-stagetrial.What...
19 precision testing groups formed the International Precision Testing Industry Alliance
2023-12-31 / GlobalBio & Investment
Unityisstrength!19precisiontestinggroupsformedthe"InternationalPrecisionTestingIndustryAlliance"(#LDTS Alliance)inDecember2023.RogerLiu,LDTSAlliance'sChairmanandCEOat 亞洲準譯AsiaPathogenomi...
TAVI compiled over a century of Taiwan's vaccine history into the book
2023-12-31 / GlobalBio & Investment
Knowledgeispower.TheTaiwanAssociationforVaccineIndustry(#TAVI)recentlycompiledoveracenturyofTaiwan'svaccinehistoryintothebook"AChronicleofTaiwan'sVaccineIndustry.",whichaimstopassonk...
Win favor with Japanese investor: Insights from the 2023 Medtech Starthub
2023-12-31 / GlobalBio & Investment
WanttowinfavorwithJapaneseinvestors?Focusonworkplacecultureandstrongpartnerships.Diveintotheinsightsfromthe2023MedtechStarthubeventwith #Globalbio'srecap! ReadmoretodiscoverthekeystocapturingJapan...
